Insulife AS is a Norwegian AS based in Oslo, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 2020, the company reported revenue of NOK 59.5k in its latest annual filing.
Utvikle, eie, produsere, markedsføre og drive salg av spray baserte legemidler samt det som står i forbindelse med dette. Selskapet skal også kunne delta i andre virksomheter med økonomiske formål.
In its most recent annual report (2025), Insulife AS reported revenue of NOK 59.5k, an increase of 6% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of NOK 14.0m, and the EBITDA margin stood at -22,236.7%.
At the end of 2025, equity financed 36.9% of the balance sheet, and current assets covered short-term debt 0.3 times.
Frequently asked questions
What is the Org number of Insulife AS?
Insulife AS is registered with Brønnøysundsregistrene under Org 925128554.
What is the revenue of Insulife AS?
Insulife AS reported revenue of NOK 59.5k in 2025.
Who is the CEO of Insulife AS?
Åge Nærdal is the CEO of Insulife AS.
Who is the chairman of Insulife AS?
Petter Wessel Bjornstad chairs the board of Insulife AS, in role since 2022.
Where is Insulife AS headquartered?
Insulife AS's registered address is Gaustadalléen 21.
